Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиГодовой отчет за 2023 год
добавлен 18.11.2024
Aeglea BioTherapeutics Мультипликаторы 2011-2024 | AGLE
Мультипликаторы по годам Aeglea BioTherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.2 | -0.0 | -0.2 | -5.2 | -2.9 | -4.2 | -3.8 | -1.8 | - | - | - | - | - |
P/S |
93.5 | 0.6 | 0.7 | 19229.8 | - | 48.2 | 20.0 | 8.5 | - | - | - | - | - |
EPS |
13.8 | -24.9 | -25.0 | -1.5 | -2.5 | -2.1 | -1.8 | -2.2 | -19.2 | - | - | - | - |
EV (Enterprise Value) |
-32.8 млн | -12.7 млн | 21.5 млн | 352 млн | 230 млн | 175 млн | 96.9 млн | -4.39 млн | -26.7 млн | -1.56 млн | 1.41 млн | - | - |
EBITDA per Share |
-35 | -24.7 | -24.4 | -1.51 | -2.5 | -2.17 | -1.81 | -2.22 | - | - | - | - | - |
EV/EBITDA |
-4.3 | -4.4 | -2.6 | -3.7 | -3.3 | 0.4 | - | - | - | - | - | ||
PEG |
-0.0 | -0.0 | -0.0 | 1.6 | 0.19 | 0.23 | -0.2 | 0.06 | - | - | - | - | - |
P/B |
0.3 | 0.0 | 0.1 | 3.0 | 3.8 | 2.8 | 2.1 | 0.6 | - | - | - | - | - |
P/CF |
-0.8 | -0.0 | -0.2 | -5.5 | -3.4 | -5.7 | -4.1 | -2.1 | - | - | - | - | - |
ROE % |
-184.11 | -166.61 | -78.39 | -57.85 | -130.25 | -65.77 | -54.11 | -34.46 | - | - | - | - | - |
ROA % |
-99.10 | -117.81 | -59.86 | -50.05 | -94.07 | -57.05 | -48.57 | -32.35 | - | - | - | - | - |
ROCE % |
-131.67 | -168.53 | -78.21 | -58.27 | -123.93 | -67.35 | -54.86 | -34.72 | - | - | - | - | - |
Current Ratio |
4.7 | 3.4 | 4.2 | 7.4 | 4.1 | 7.5 | 9.8 | 16.8 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | 215.8 | 95.8 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Aeglea BioTherapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.36 | -0.86 | -1.2 | - | -9.34 | -56.79 | -4.89 | - | -4.84 | -0.27 | -0.37 | - | -0.31 | -0.1 | -0.28 | -0.35 | -0.29 | -0.4 | -0.57 | -0.65 | -0.66 | -0.55 | -0.59 | -0.62 | -0.54 | -0.46 | -0.49 | -0.39 | -0.48 | -0.47 | -0.47 | -0.41 | -0.47 | -0.46 | -7.1 | -6.36 | -5.57 | -2.44 | -4.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | -4.89 | - | -4.66 | -0.27 | -0.36 | - | -0.29 | -0.1 | -0.27 | -0.47 | -0.28 | -0.4 | -0.57 | -0.75 | -0.66 | -0.56 | -0.61 | -0.63 | -0.55 | -0.46 | -0.49 | -0.4 | -0.48 | -0.47 | -0.47 | -0.41 | -0.47 | -0.46 | -7.08 | -5.28 | -5.48 | -2.38 | -4.28 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-43.92 | -6.49 | 108.57 | 66.28 | 39.29 | -4.04 | -135.25 | -93.15 | -113.04 | -105.94 | -85.16 | -40.35 | -56.60 | -49.60 | -59.18 | -57.85 | -77.38 | -100.39 | -115.07 | -130.25 | -116.57 | -98.33 | -82.30 | -65.77 | -56.56 | -54.52 | -53.74 | -54.11 | -49.94 | -44.20 | -39.65 | -34.46 | -7.80 | 17.48 | 32.53 | 50.86 | 32.91 | 17.54 | 11.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-53.64 | -56.60 | -136.84 | -143.61 | -163.52 | -164.09 | -104.33 | -78.68 | -94.41 | -60.85 | -65.50 | -31.52 | -45.57 | -40.99 | -49.60 | -50.05 | -61.84 | -76.62 | -85.02 | -94.07 | -87.40 | -76.79 | -67.24 | -57.05 | -49.44 | -48.16 | -47.87 | -48.57 | -45.18 | -40.44 | -36.71 | -32.35 | -34.49 | -34.02 | -29.62 | -29.22 | -18.91 | -10.08 | -6.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-52.61 | -28.22 | 60.36 | 28.38 | 0.62 | -34.62 | -138.05 | -94.05 | -113.93 | -106.04 | -85.03 | -40.23 | -56.51 | -49.60 | -59.38 | -58.27 | -78.45 | -102.35 | -117.92 | -133.71 | -119.94 | -101.24 | -84.59 | -67.42 | -57.89 | -55.62 | -54.63 | -54.98 | -50.62 | -44.74 | -40.11 | -34.79 | -7.99 | 17.41 | 32.58 | 50.95 | 32.95 | 17.57 | 11.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.5 | 7.1 | 6.0 | 4.7 | 3.2 | 1.0 | 2.8 | 3.4 | 3.8 | - | 3.9 | 4.2 | 4.8 | 5.3 | 4.1 | 7.4 | 7.4 | 7.4 | 7.4 | 3.6 | 3.6 | 3.6 | 3.6 | 7.5 | 7.5 | 7.5 | 7.5 | 9.8 | 9.8 | 9.8 | 9.8 | 16.4 | 16.4 | 16.4 | 16.4 | 15.2 | 15.2 | 15.2 | 15.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | 71.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | 71.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | 71.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD